CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Previously Reported	Revision of Prior Period, Adjustment	Common Stock	Common Stock Previously Reported	Common Stock Revision of Prior Period, Adjustment	Additional Paid-in Capital	Additional Paid-in Capital Previously Reported	Additional Paid-in Capital Revision of Prior Period, Adjustment	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment	Accumulated Deficit Previously Reported	Accumulated Deficit Revision of Prior Period, Adjustment
Beginning balance (in shares) at Dec. 31, 2020	0		68,589,913	68,589,913
Beginning balance at Dec. 31, 2020	$ 0		$ 49,894	$ (49,894)
Ending balance (in shares) at Sep. 30, 2021	0
Ending balance at Sep. 30, 2021	$ 0
Beginning balance (in shares) at Dec. 31, 2020					31,432,477	9,524,440	21,908,037
Beginning balance at Dec. 31, 2020	(949)		$ (50,843)	$ 49,894	$ 3	$ 10	$ (7)	$ 57,097	$ 7,196	$ 49,901	$ (58,049)		$ (58,049)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
PIPE proceeds (in shares)					15,000,000
PIPE proceeds	150,000				$ 2			149,998
Merger financing (in shares)					39,408,662
Merger financing	251,109				$ 4			251,105
Consideration paid to selling stockholders	(329,560)							(329,560)
Transaction costs	(33,534)							(33,534)
Merger warrants liability	(44,272)							(44,272)
Stock options exercised (in shares)					2,073,162
Stock options exercised	629							629
Stock-based compensation expense (in shares)					2,850,000
Stock-based compensation expense	12,862							12,862
Stock warrant exercise (in shares)					6,708,070
Stock warrant exercise	13,102				$ 1			13,101
Net (loss) income	13,727										13,727
Ending balance (in shares) at Sep. 30, 2021					97,472,371
Ending balance at Sep. 30, 2021	$ 33,114				$ 10			77,426			(44,322)
Beginning balance (in shares) at Dec. 31, 2020	0		68,589,913	68,589,913
Beginning balance at Dec. 31, 2020	$ 0		$ 49,894	$ (49,894)
Ending balance (in shares) at Dec. 31, 2021	0
Ending balance at Dec. 31, 2021	$ 0
Beginning balance (in shares) at Dec. 31, 2020					31,432,477	9,524,440	21,908,037
Beginning balance at Dec. 31, 2020	$ (949)		$ (50,843)	$ 49,894	$ 3	$ 10	$ (7)	57,097	$ 7,196	$ 49,901	(58,049)		$ (58,049)	$ 0
Ending balance (in shares) at Dec. 31, 2021	97,574,171				97,574,171
Ending balance at Dec. 31, 2021	$ 40,799	$ (1,962)			$ 10			77,632			(36,843)	$ (1,962)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2016-02 [Member]
Beginning balance (in shares) at Jun. 30, 2021	0
Beginning balance at Jun. 30, 2021	$ 0
Ending balance (in shares) at Sep. 30, 2021	0
Ending balance at Sep. 30, 2021	$ 0
Beginning balance (in shares) at Jun. 30, 2021					96,821,615
Beginning balance at Jun. 30, 2021	16,091				$ 10			74,143			(58,062)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock options exercised (in shares)					650,756
Stock options exercised	186							186
Stock-based compensation expense	3,097							3,097
Net (loss) income	13,740										13,740
Ending balance (in shares) at Sep. 30, 2021					97,472,371
Ending balance at Sep. 30, 2021	$ 33,114				$ 10			77,426			(44,322)
Beginning balance (in shares) at Dec. 31, 2021	0
Beginning balance at Dec. 31, 2021	$ 0
Ending balance (in shares) at Sep. 30, 2022	0
Ending balance at Sep. 30, 2022	$ 0
Beginning balance (in shares) at Dec. 31, 2021	97,574,171				97,574,171
Beginning balance at Dec. 31, 2021	$ 40,799	$ (1,962)			$ 10			77,632			(36,843)	$ (1,962)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Merger financing	0
Stock options exercised (in shares)					284,321
Stock options exercised	65							65
Vesting of restricted stock units (in shares)					750,823
Repurchase of restricted stock for payroll tax withholding (in shares)					(173,365)
Repurchases of restricted stock for payroll tax withholding	(293)							(293)
Stock-based compensation expense	4,753							4,753
Net (loss) income	$ (23,444)										(23,444)
Ending balance (in shares) at Sep. 30, 2022	98,435,950				98,435,950
Ending balance at Sep. 30, 2022	$ 19,918				$ 10			82,157			(62,249)
Beginning balance (in shares) at Jun. 30, 2022	0
Beginning balance at Jun. 30, 2022	$ 0
Ending balance (in shares) at Sep. 30, 2022	0
Ending balance at Sep. 30, 2022	$ 0
Beginning balance (in shares) at Jun. 30, 2022					98,334,413
Beginning balance at Jun. 30, 2022	26,308				$ 10			80,394			(54,096)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock options exercised (in shares)					8,886
Stock options exercised	5							5
Vesting of restricted stock units (in shares)					127,565
Repurchase of restricted stock for payroll tax withholding (in shares)					(34,914)
Repurchases of restricted stock for payroll tax withholding	(49)							(49)
Stock-based compensation expense	1,807							1,807
Net (loss) income	$ (8,153)										(8,153)
Ending balance (in shares) at Sep. 30, 2022	98,435,950				98,435,950
Ending balance at Sep. 30, 2022	$ 19,918				$ 10			$ 82,157			$ (62,249)